Switch to:
More From Other Websites
Buy These 4 Stocks and Beat Biotech's Slump Sep 30 2016
Amgen (AMGN) Migraine Drug Hits Phase III Primary Endpoint Sep 30 2016
ETF’s with exposure to Amgen, Inc. : September 30, 2016 Sep 30 2016
Amgen’s Kyprolis Fails in Trial (AMGN) Sep 29 2016
Asian stocks lower on renewed worries about banking sector Sep 29 2016
Amgen’s Backup Plan for Kyprolis (AMGN) Sep 29 2016
[$$] Zymeworks Gains Immuno-Oncology Drugs Through Daiichi Sankyo Deal Sep 29 2016
Long Wait for Biosimilar Amjevita (AMGN) Sep 29 2016
Stocks skid as drugmakers fall, then bank woes deepen losses Sep 29 2016
Amgen Maintains Migraine Drug Lead (AMGN) Sep 29 2016
Amgen Migraine Drug Likely To Beat Eli Lilly, Alder, Teva To Market Sep 29 2016
Amgen Arrowhead Announce Two Cardiovascular Collaborations (AMGN, ARWR) Sep 29 2016
Arrowhead (ARWR): Collaborations with Amgen for Two Cardiovascular Programs Sep 29 2016
Arrowhead Pharmaceuticals (ARWR) Stock Surges on Amgen Cardiovascular Drug Partnerships Sep 29 2016
CORRECTED: mgen and Arrowhead Pharma agree 2 cardiovascular collaborations Sep 29 2016
7 Healthcare Stocks in Focus on World Heart Day Sep 29 2016
Amgen, Arrowhead team up on gene-therapies for heart disease Sep 29 2016
Amgen, Inc. breached its 50 day moving average in a Bearish Manner : AMGN-US : September 29, 2016 Sep 29 2016
Amgen And Arrowhead Pharmaceuticals Announce Two Cardiovascular Collaborations Sep 29 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK